top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Autore Ecke Thorsten
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (240 p.)
Soggetto topico Medicine
Soggetto non controllato Metallothionein
urothelium
urothelial cancer
cadmium exposure
zinc transporter
bladder
TAGLN
F-actin
PTEN
p53
tumorigenesis
proliferation
invasion
TERT promoter mutations
FGFR3
non muscle invasive bladder cancer
BCG therapy
bladder cancer
JAK-STAT pathway
combination therapy
oncolytic adenovirus
virotherapy
STAT3/5 inhibitor
JAK inhibitor
XVir-N-31
bladder cancer detection
urinary biomarkers
DNA methylation
ECRG4
ITIH5
biomarker
cancer
grade
metabolomics
MS
NMR
biomarkers
tumor markers
prognosis
heparanase
syndecan-1
heparan sulfate proteoglycans (HSPGs)
urothelial carcinoma
miRNA
quantitative PCR
tumor marker
voided urine cytology
KDM7A
histone demethylase
TC-E 5002
androgen receptor
drug resistance
non-invasive detection
telomerase
somatic mutations
TERT promoter region
muscle-invasive bladder cancer
chemotherapy
immunotherapy
personalized medicine
predictive biomarker
survivin
BIRC5
macrophage
KRT20
ERBB2
MIBC
prediction
RT-qPCR
adjuvant chemotherapy
survival
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557142003321
Ecke Thorsten  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Outcomes and Therapeutic Management of Bladder Cancer
Outcomes and Therapeutic Management of Bladder Cancer
Autore Moschini Marco
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (120 p.)
Soggetto topico Medicine
Soggetto non controllato bladder cancer
robotic-assisted
open
radical cystectomy
survival
propensity score
age
urothelial carcinoma
outcome
anesthesia recovery periods
cognitive impairment
gamma-cyclodextrins
neuromuscular blockade
robotic radical cystectomy
glycogen
clear-cell adenocarcinoma
urinary bladder
SEER program database
female
intracorporeal neobladder
outcomes
robotic
sex-sparing
methylation
biomarkers
FOXA1
GATA3
KRT20
molecular markers
mRNA
muscle-invasive bladder cancer
PCR
human epidermal growth factor receptor 2
indoleamine 2,3-dioxygenase
programmed death ligand-1
immunotherapy
nodal disease
pN1
neoadjuvant
adjuvant
chemotherapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114503321
Moschini Marco  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui